Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

43%

3 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 4

2(40.0%)

N/A

1(20.0%)

Early Phase 1

1(20.0%)

Phase 3

1(20.0%)

5Total

Phase 4(2)

N/A(1)

Early Phase 1(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT05983003Completed

Research on Identifying and Treatment Prognosis of Chronic Rhinosinusitis Based on Image and Sequencing Data

Role: collaborator

NCT06279104Recruiting

A Comparative Study of the Treatment of Real-world Patients With Clear Cell Carcinoma of the Ovary

Role: collaborator

NCT04048161Phase 4Completed

Study of Tacrolimus vs Mycophenolate Mofetil in Pediatric Patients With Nephrotic Syndrome

Role: collaborator

NCT02639650Phase 3Recruiting

Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor

Role: collaborator

NCT02622750Early Phase 1Unknown

Triple-branch Stent Graft Placement and Total-arch Replacement for the Treatment of Acute DeBakey I Aortic Dissection

Role: collaborator

NCT03110198Phase 4Unknown

Mesalazine With Hydrocortisone Sodium Succinate Enema for 4-Week Treatment in Patients With Ulcerative Colitis

Role: collaborator

NCT03098264Not ApplicableUnknown

Safety and Efficacy of Simultaneous or Staged Surgery on Complicated Hepatolithiasis

Role: collaborator

All 7 trials loaded